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Spectroscopic oximetry in the eye: a review 1 
ABSTRACT 2 
Introduction: Non-invasive measurement of blood oxygen saturation via spectroscopic imaging has 3 
facilitated insights into the development and progression of a variety of ocular conditions, including 4 
retinal vascular occlusion, diabetic retinopathy and glaucoma.  Major developments since the late 90s 5 
have been enabled by advancements in imaging technology, computational image analysis, and 6 
experimental methods.  7 
Areas covered: We review the theory of spectroscopic oximetry, the ocular blood vessels targeted for 8 
oximetry, imaging systems used for oximetry, and oximetry validation methods. Important 9 
physiological and clinical insights provided by oximetry in the eye are detailed. 10 
Expert commentary: Oximetry has revealed physiological norms and auto-regulatory effects in the 11 
retina, choroid, episcleral, and bulbar conjunctival blood vessels. Retinal oximetry has provided crucial 12 
insight into the development of diabetic retinopathy and glaucoma, and has enhanced the evaluation 13 
and treatment of retinal vessel occlusion. Commercially available retinal oximetry systems have 14 
enabled oximetry in the clinic. The development more sophisticated phantoms that resemble in vivo 15 
environments has oximetry validation in diverse oximetry applications. New insights into ocular 16 
physiology and disease are likely to be gleaned from future studies. 17 
-------------------------------------------------------------------------------------------------------------------------------------- 18 
Keywords: oximetry, retina, autoregulation, diabetes, glaucoma, vessel occlusion, choroid, bulbar 19 
conjunctiva. 20 
 21 
1. INTRODUCTION  22 
Oximetry - the measurement of blood oxygen saturation (OS) – can be achieved non-invasively by 23 
measuring the spectrum of light absorbed by blood. This is achieved by imaging the eye at two or more 24 
wavelengths of light, and calibrating the OS to absorption of light by either (1) assuming standard 25 
normal OS values or (2), by combining information from many wavelengths into a sophisticated 26 
physical model incorporating the known spectral properties of blood with other biological and optical 27 
parameters. 28 
Since the late 1950s, retinal oximetry has progressed from a photographic technique [1–3] through 29 
to the cutting edge of digital imaging technology with automated computational analysis.[4,5] Over 30 
the decades, retinal oximetry has revealed valuable insights into retinal physiology and metabolism 31 
under conditions such as flicker illumination,[6,7] dark adaptation,[8] hyperoxia,[4,9,10] and acute 32 
mild hypoxia.[11,12] Further, retinal oximetry has provided insights into the development and 33 
progression of ocular diseases such as diabetic retinopathy,[13–17] glaucoma,[18–22] and retinal 34 
vessel occlusion.[23–26] Recently, oximetry has allowed the understanding of the fundamental 35 
physiological oxygen dynamics of the bulbar conjunctival circulation,[27] the episcleral vessels,[27] 36 
and the choroidal circulation.[28]  37 
From a patient’s perspective, the experience of oximetry imaging in the eye is typically 38 
indistinguishable from conventional retinal-fundus imaging because oximetry systems are typically 39 
based on a modified conventional retinal-fundus cameras[4,11,16] or multi-wavelength scanning laser 40 
ophthalmoscopes.[10,29] As such, a great deal of oximetry innovation has arisen from improved 41 
image recording, computational image analysis, and the development of complimentary functional 42 
oxygen-sensitive stress interventions that allow insight into OS under altered metabolic conditions. 43 
These intervention tests include subjecting subjects to hyperoxia,[6,7] acute mild hypoxia,[11,12] or 44 
altered light-exposure conditions.[6–8] As well as physiological and clinical insights, these intervention 45 
tests help validate the accuracy of oximetry measurements. 46 
Invariably, advances in oximetric-imaging technology have provided new insights and applications. 47 
In particular, the development of commercially available retinal oximetry devices with automated 48 
analysis – such as the Oxymap T1 (Oxymap ehf, Iceland )[4] and Imedos (Imedos Systems UG, 49 
Germany)[16] retinal oximetry systems - have enabled oximetry in the clinic, allowing insights into 50 
treatment of individual patients[24] and also enabling clinicians to build large datasets with high 51 
statistical power. Additionally, the development of oximetry systems with capability for imaging with 52 
greater temporal[11] and spatial resolution[29] enable development of novel techniques and fresh 53 
insights by investigating OS of smaller blood vessels or by studying OS dynamics on a shorter timescale. 54 
For example, snapshot multispectral imaging technology has enabled measurement of rapid oxygen 55 
diffusion in the bulbar conjunctiva[27] and adaptive optics have enabled oximetry in small retinal 56 
vessels, which are not typically studied due to their small diameters.[29] 57 
This review focuses on the current technology and methods of spectroscopic oximetry, new 58 
applications in spectroscopic oximetry of the eye, and the clinically useful ophthalmological insights 59 
that have been consequently enabled. 60 
2. PRINCIPLE OF SPECTROSCOPIC OXIMETRY 61 
Spectroscopic oximetry is enabled by the distinct absorption spectra of oxygenated haemoglobin 62 
(O2Hb) and deoxygenated haemoglobin (Hb) as shown in Figure 1: partial oxygenation results in an 63 
absorption spectrum that is a weighted average of these two spectra. This difference in optical 64 
absorption can be clearly seen by eye for a low-volume sample of blood: highly oxygenated blood 65 
appears bright red to the eye, whereas deoxygenated blood is much darker in appearance. Whilst this 66 
difference in optical absorption is readily observed in ex vivo blood samples, it is highly challenging to 67 
accurately quantify in the complex optical environment of the eye due to the influence of optical 68 
scattering[30] and the uncertain absorption of light by variable background pigmentation.[9,31] There 69 
are two approaches to spectroscopic oximetry measurement and analysis: two-wavelength oximetry 70 
and multi-wavelength oximetry.  71 
 72 
 73 
Figure 1. The absorption spectra of oxygenated haemoglobin (O2Hb) and deoxygenated 74 
haemoglobin (Hb) at visible and near infra-red wavelengths. 75 
2.1. Two-wavelength oximetry 76 
In two-wavelength oximetry, blood vessels are imaged at one OS-sensitive contrast wavelength, 77 
and another – typically OS-insensitive (isobestic) - wavelength. The optical transmission of blood 78 
vessels (𝑇𝜆) is measured at each wavelength, and the optical density (𝑂𝐷), defined as: 𝑂𝐷𝜆 =79 
 −𝑙𝑜𝑔 (𝑇𝜆), is computed. From this, the optical density ratio (𝑂𝐷𝑅), defined as 𝑂𝐷𝑅 =  
𝑂𝐷𝜆 𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡
𝑂𝐷𝜆 𝑖𝑠𝑜𝑏𝑒𝑠𝑡𝑖𝑐
, is 80 
calculated. If an isobestic wavelength is used, then for a blood vessel of a given diameter, ODR is 81 
theoretically directly proportional to blood oxygen saturation (verified experimentally in 1959)[1], and 82 
so ODR can be empirically related to OS by measuring ODR of blood vessels at two OS levels followed 83 
by calibration against a blood vessels of known oxygenation (i.e. using pulse oximetry or blood gas 84 
measurement). The theory of two-wavelength oximetry is based upon the simple Beer-Lambert law 85 
of light transmission, which neglects the effects of optical scattering that is incorporated into the 86 
modified Beer-Lambert law.[31] For visualisation purposes, ODR or OS is often overlaid as a colour 87 
map on images of blood vessels (see Figure 2 for an example).[4] 88 
 89 
Figure 2. ODR colour-map of bulbar conjunctiva (BC) and episcleral (ES) vessels at (a) 90 
normoxia, and (b) acute mild hypoxia. Reproduced with permission from MacKenzie et 91 
al., (2016).[32] 92 
The optimal transmission of a blood vessel for accurate oximetry is around 37%, [33] but, because 93 
the optical transmission of blood vessels varies  according to several factors – including vessel 94 
diameter -  an optical transmission of between 10 % and 70 % has been found to work well.[33] For 95 
retinal oximetry, the combination of 570 nm (isobestic) and 600 nm (contrast) wavebands has been 96 
commonly adopted for retinal oximetry.[4,11,31] However, the optimal wavelength combinations 97 
used for any oximetry study are dependent upon the calibre of vessels of interest and the efficiency 98 
of optical imaging and detection systems.  99 
Care is required in calibration of two-wavelength oximetry. In early retinal oximetry studies retinal 100 
arterial OS was calibrated by comparison with ex vivo brachial-artery blood samples and blood gas 101 
measurement.[1–3] Whilst useful for establishing relations between retinal arterial OS and systemic 102 
arterial OS, ex vivo blood gas measurement is undesirable or not feasible and has been rendered 103 
unnecessary by the advent of fingertip pulse oximetry which allows non-invasive estimation of 104 
systemic arterial OS. However, calibrating arterial OS alone can lead to artefacts in estimated venous 105 
OS. For example, it has been shown that ODR is dependent on blood vessel diameter and background 106 
pigmentation; so two-wavelength oximetry requires calibration correction factors that are dependent 107 
upon both background pigmentation and blood vessel diameter.[9,31]  It has recently been postulated 108 
that the laminar flow from multiple tributary branching veins, which  leads to non-inform blood 109 
oxygenation within a vein may also degrade estimation of OS in retinal veins, which is based upon 110 
homogeneous blood oxygenation. This significance of this factor requires experimental testing and 111 
validation.[34] 112 
Two-wavelength oximetry is the basis for the Oxymap and Imedos commercial retinal imaging 113 
devices which have found considerable use in clinical applications (see Section 6). 114 
2.2. Multispectral oximetry techniques 115 
Multispectral oximetry is broadly defined as any oximetry technique that incorporates information 116 
from three or more spectral wavebands to calculate OS. 117 
2.2.1. Three-wavelength oximetry  118 
The simplest form of multispectral oximetry, three-wavelength oximetry, [35] utilises two isobestic 119 
wavelengths relatively close to each other on the wavelength spectra combined with a wavelength 120 
providing oximetric contrast. From the two isobestic two wavelengths it is possible to quantify the 121 
scattering of light by blood, and thus to appropriately alter estimation of blood-vessel transmission 122 
via the modified Beer Lambert law.[35] Three-wavelength retinal oximetry was applied to the retinal 123 
imaging with a scanning laser device by Delori in the 1980s and 1990s.[36,37] However, three 124 
wavelength oximetry was somewhat difficult to apply because of the requirements of three 125 
wavebands where blood exhibits similar optical scattering properties; this limited the range of useful 126 
wavebands to which it can be applied.[33] As such, three-wavelength oximetry has tended to be 127 
superseded by multispectral oximetry using four or more bands. 128 
2.2.2. Multispectral oximetry models 129 
Multispectral oximetry models enable estimation of OS by incorporating the optical transmission 130 
of blood at a number of wavebands to isolate the absorption of light by blood and estimate or 131 
compensate for other optical parameters, e.g. the scattering of light by blood and tissue, or the optical 132 
absorption by melanin pigmentation. Typically, the transmissions of blood vessels are measured and 133 
the experimental transmission compared to a theoretical model incorporating these parameters. This 134 
enables direct estimation of OS without need of a reference value; i.e. multispectral algorithms are 135 
“calibration free”.  Thus, multispectral oximetry algorithms can provide quantitative oximetry in blood 136 
vessels where OS levels have not yet been measured by other means (e.g. in the spinal cord)[38] or in 137 
blood vessels that may be expected to be very different from physiological norms (e.g. studying 138 
angiogenesis in tumour development)[39,40]. However, validation of estimated OS from multispectral 139 
oximetry algorithms is normally desirable, and provides vital information for the wider field of 140 
oximetry (see Section 5).  141 
The number of wavebands incorporated into a multispectral imaging system varies greatly. Some 142 
oximetry studies incorporate many wavebands (e.g. between 25 and 76 wavebands) into a 143 
‘hyperspectral’ model (see Table 1). Hyperspectral imaging offers the advantage a comprehensive 144 
measurement of blood vessel transmission, but as a result of this, hyperspectral imaging systems are 145 
typically burdened with a long acquisition time (i.e. > 1 minute) and high data volumes for a single 146 
data set. Consequently, challenges arise from subject eye motion and alterations of OS of vessels 147 
during hyperspectral measurement. Additionally, some wavebands may be sub-optimal for oximetry; 148 
for example, blue wavelengths suffer from lower instrumental signal-to-noise ratios and high 149 
absorption by melanin pigmentation, and auto-fluorescence from blood or other tissue. Imaging 150 
spectrograph devices offer excellent spectral resolution and have been employed for spectroscopy of 151 
the eye,[41] but have only found limited usage because there are no significant advantages associated 152 
with over-sampling the absorbance spectra of blood for oximetry. 153 
Multispectral oximetry models incorporating a few (typically < 10) key wavelengths have achieved 154 
high quality oximetry, whilst reducing acquisition time required for spectral data acquisition. Of 155 
particular note is the development of ‘snapshot’ multispectral imaging techniques where several 156 
wavebands are acquired simultaneously; this avoids artefacts associated with misregistration of time-157 
sequentially recorded images.[42] The simplest form of snapshot multispectral imaging involves to 158 
spliting the imaged light with an optical beam-splitter and then filter each resultant image separately 159 
with bandpass filters, or by using a dichroic mirror, [4,42] however, this becomes optically inefficient 160 
for large numbers of bands and problematic to implement with a single detector. Several snapshot 161 
multispectral imaging devices that require only a single detector have been developed, including use 162 
of a lenslet array[43] and the Image Mapping Spectrometer[44] using degmented mirrors; however to 163 
date neither of these approaches have been applied extensively to oximetry. A snapshot imaging 164 
system which has found significant use for oximetry is the Image Replicating Imaging Spectrometer 165 
(IRIS).[11,45] This optically efficient device enables video-rate imaging at eight distinct wavebands 166 
optimised for retinal oximetry. The high temporal resolution and 8 wavebands afforded by IRIS has 167 
enabled several new oximetry applications, including direct observation of oxygen release by red 168 
blood cells.[46]  169 
Table 1. Retinal oximetry studies utilising multispectral imaging oximetry 170 
algorithms. 171 
 
Study 
 
Wave-range 
 
Known 
parameters 
 
 
Estimated 
parameters 
 
 
Key reported OS  
(i.e. normal OS at normoxia - unless 
otherwise stated) 
 
Schweitzer et al., 
(1999)[47] 
510 – 586 nm 
76 wavebands 
ε, εmel OS, c, d, η 
A: 92.2 ± 4.1 % 
V: 57.9 ± 9.9 % 
Drewes et al., 
(1999)[48] 
629, 678, 821, & 
899 nm. 
ε OS, S, c, d 
A: 101 % 
V: 65 % 
Smith et al., 
(2000)[49] 
488, 635, 670, 
752, & 830 nm 
ε 
OS, S, c, d, 
η 
V: 42 - 56 % 
Alabboud et al., 
(2007)[50] 
500 – 700 nm 
27+ wavebands 
 
ε, S 
OS, d, c, η 
 
A: 96 % 
V: 55 % 
Mordant et al., 
(2011)[51] 
500 - 650 nm 
300 wavebands 
ε, S 
OS, d, c, η 
 
A: 104 % 
V: 35 % 
Salyer et al.,  
(2006)[52] 
420 – 700 nm 
29 wavebands 
ε OS, S 
Arterial OS correlated well with ex 
vivo blood OS measurements 
Khoobei et al., 
(2007)[53] 
522 – 586 nm 
7 wavebands 
ε OS 
A: 92 % 
V: 76 % 
Arimoto et al., 
(2010)[54] 
510 – 600 nm 
45 wavebands 
ε OS N/A: relative OS 
Furukawa et al., 
(2012)[54] 
510 – 600 nm 
7 wavebands 
ε OS N/A: relative OS 
Gao et al., 
(2012)[44] 
510 - 586 nm 
8 wavebands 
ε OS N/A: relative OS 
     
 172 
Key: A = arteries, V = veins. SO2 = oxygen saturation, ε = extinction coefficient of Hb and O2Hb, εmel = extinction 173 
coefficient of melanin, S = scattering contribution; c = concentration of haemoglobin, η = single/double pass 174 
contribution factor; d = diameter of vessels; K = contrast reduction factor. 175 
  176 
 177 
3. BLOOD VESSELS TARGETED FOR OXIMETRY  178 
3.1. Retinal oximetry 179 
To date, the retinal vasculature has been the primary target for oximetry investigations in the eye. 180 
The retina is a site of extremely high metabolic demand, and problems with retinal blood flow can 181 
lead to a number of serious ocular conditions, including: retinal vascular occlusion[23–26] and diabetic 182 
retinopathy.[13–17]  Further, in ocular conditions characterised by cell loss e.g. glaucoma, estimation 183 
of oxygen utilisation has provided new insights.[18–22] 184 
Choroidal oximetry 185 
A recent development in oximetry is the targeting of choroidal vessels for oximetry in subjects with 186 
very low retinal pigmentation. The lack of retinal pigmentation allows light to traverse through the 187 
retina and and dense choroidal vasculature. Kristjansdottir et al., (2013)[28] conducted an imaging 188 
study of OS of choroidal blood vessels in healthy subjects; results were reported in terms of ODR 189 
because ODR to OS calibration coefficients for choroidal vessels are not known and high levels optical 190 
scattering prevent the use of existing oximetry models. For example, some choroidal vessels have a 191 
negative optical density; i.e. they appear brighter than surrounding tissue. To date, a calibration 192 
scheme for choroidal oximetry calibration has not been derived. However, this study revealed a very 193 
low artery-vein difference of 4% in the choroid (instead of the typical ~30% artery-vein difference in 194 
retinal vessels).[11,28] Further studies of the choroidal circulation are required to understand what 195 
further physiological and clinical insights choroidal oximetry could bring. 196 
3.2. Bulbar conjunctival oximetry 197 
A recent oximetry study by MacKenzie et al., (2016)[32]  revealed that bulbar conjunctival blood 198 
vessels have oxygen dynamics that are remarkably different from any other blood vessels in the eye. 199 
The bulbar conjunctival blood vessels are situated within the thin conjunctival membrane on the outer 200 
surface of the sclera, and consequently are in direct contact with ambient air. This unique position of 201 
the bulbar conjunctival vessels leads to oxygen diffusion occurring from air into the bulbar conjunctival 202 
blood vessels. Consequently, all bulbar conjunctival blood vessels exposed to air will be highly 203 
oxygenated, with little to no artery-vein difference. Study of bulbar conjunctival oxygen dynamics 204 
could potentially yield insights into microvascular oxygen dynamics and related parameters. This may 205 
be of particular interest for the study of oxygen dynamics in diabetes, where microvascular vessel wall 206 
hardening is known to occur.[32] 207 
3.3. Episcleral oximetry 208 
Oximetry of the superficial episcleral blood vessels embedded into the sclera has recently been 209 
achieved for the first time by MacKenzie et al (2016).[32] This study observed that when episcleral 210 
vessels are exposed to a temporary hypoxic intervention, episcleral vessels dilated and episcleral OS 211 
decreased. This auto-regulatory behaviour is similar to the autoregulation observed in retinal vessels 212 
under similar hypoxic conditions.[11] Because episcleral vessels can be imaged on the surface of the 213 
sclera, it has been suggested that episcleral vessels could be used as a proxy for retinal OS in situations 214 
where retinal imaging is not feasible; e.g. in patients with cataracts. Alternatively, episcleral vessels 215 
could be used as a comparison point with retinal vessels to study ocular autoregulation. Further 216 
studies of episcleral vessels is required before their utility for clinically relevant oximetry can be 217 
ascertained.[32] 218 
3.4. Oximetry elsewhere in the body 219 
It is noteworthy that oximetry techniques originally developed for oximetry in the eye have 220 
benefited oximetry applications elsewhere in the body. For example, multispectral imaging oximetry 221 
has been employed to investigate diverse applications, including murine brain vascular oximetry,[55] 222 
diabetic foot-ulcer development,[56] bowel laproscopy,[57] skin blood flow,[58] the study of skin 223 
damage due to beta radiation exposure,[59] labial, periodontal, and sublingual microvasculature,[60] 224 
cancer tumour development in murine models,[39,40] and oximetry of the rat spinal cord dorsal vein 225 
for studying the development of multiple sclerosis disease models.[38] 226 
4. SPECTROSCOPIC IMAGING MODALITIES FOR THE EYE 227 
The majority of oximetry studies in the eye are conducted with retinal-fundus cameras adapted for 228 
two wavelength or multispectral imaging. Dual wavelength imaging can be enabled by splitting a 229 
broadband retinal image with a dichroic beam-splitter, spectrally filtering the resultant images, and 230 
then recording with one or more detectors.[4,31] Alternatively, wavebands may be recorded using 231 
separate channels of a three-colour RGB CCD detector with additional spectral filtering to ehance 232 
spectral discrimination.[9,38] The majority of multispectral and hyperspectral imaging studies have 233 
employed time-sequential filtering of broadband retinal images, utilising either multiple bandpass 234 
filters, a liquid-crystal tuneable filter (LCTF),[21,50,51,53,61,62] or an acousto-optic tuneable filter 235 
(AOTF) for spectral discrimination.[54,63,64] LCTFs and AOTFs offer the advantages electronically-236 
controlled optical waveband switching in short timescales (~ 50 ms and 25 µs respectively), with a 237 
wide-variety of accessible wavelengths.[65] The Image Replicating Imaging Spectrometer (IRIS) has 238 
enabled video-rate oximetry which has been utilised observe oxygen release by ex vivo red blood cells 239 
upon exposure to sodium dithionite.[46,66]  240 
 241 
Dual-wavelength scanning laser ophthalmoscopes (SLOs)[10,29,67,68] offer several advantages for 242 
retinal oximetry compared to fundus cameras, including improved control of stray light, reduced 243 
fundus light exposure levels, wide-field retinal scanning,[10] no requirement for pupil dilation,[68] and 244 
the option to incorporate adaptive optics to compensate for eye motion and improve imaging of small 245 
retinal blood vessels.[29] Recently this has enabled retinal oximetry of infants without mydriasis.52 246 
However, despite these advantages, SLOs are limited to available laser wavelengths, which are not 247 
optimal for oximetry,[33] so further development and testing of SLO oximetry systems is required. 248 
 249 
Slit lamps have not yet been utilised for oximetry, but could be modified for multispectral imaging. 250 
The high mangification and resolution of slit lamps could enable oximetry of blood vessels as small as 251 
individual capillaries and groups of red blood cells in the bulbar conjunctiva.[27]  252 
 253 
Figure 3. Psuedo-colour OS map of retinal vessels in an infant obtained via imaging with 254 
a scanning laser ophthalmoscope. Red indicates 100% OS, purple 0% OS. Figure 255 
reproduced from Vehmeijer et al., (2016) under a Creative Commons BY license.[68] 256 
Optical Coherence Tomography (OCT) is emerging as a potential retinal oximetry technology, but 257 
to date OCT oximetry has been applied only to murine models. In OCT, light backscattered from tissue 258 
is collected, and by coherence gating, is processed to form a 3D volumetric image of tissue. The ranging 259 
function of OCT provides the enhanced possibility of good control of the light paths defining optical 260 
absorption and with a reduced influence of scattering Spectroscopic Optical Coherence Tomography 261 
(S-OCT) has recently emerged as technology capable of recording 3D maps of OS with high spatial 262 
resolution. [69–71] Initially, S-OCT systems utilised the near infra-red illumination wavelengths 263 
commonly used by OCT systems. Unfortunately, near infra-red wavelengths suffer from weak optical 264 
absorption contrast between Hb and O2Hb, resulting in sub-optimal oximetry. Consequently, newer S-265 
OCT oximetry systems have improved oximetry capability by switching to visible wavelength 266 
illumination; visible wavelengths provide improved spectral contrast for oximetry. [72,73] However, 267 
S-OCT requires long acquisition times of up to 20 minutes for data acquisition. As such S-OCT oximetry 268 
studies have been conducted in murine models only. [74–76] 269 
Photoacoustic imaging has recently emerged as a hybrid imaging modality that combines optical 270 
spectral contrast with the tissue depth penetration of ultrasound. In photoacoustic imaging, high 271 
intensity pulsed laser light (typically < 10 ns duration per pulse) is incident on the target tissue, heating 272 
the blood by less than 0.1°C and leading to rapid expansion and contraction which generates an 273 
ultrasound pulse with an amplitude proportional to the absorption of light by blood.[77] Ultrasound 274 
imaging of the emission  therefore enables deep-tissue volumetric mapping of optical absorption. 275 
However, the high laser powers required for photoacoustic signal generation and requirement for 276 
ultrasonic transducer coupling to the eye make photoacoustic imaging a less attractive prospect for 277 
oximetry in the human eye compared to oximetry with fundus cameras. So far all photoacoustic 278 
studies of the eye have been limited to murine models. A good overview of photoacoustic ophthalmic 279 
imaging has been provided by Liu and Zhang (2016).[78]  280 
5. VALIDATION AND TESTING OF OXIMETRY MEASUREMENTS 281 
5.1 Oxygen-sensitive challenges and interventions  282 
Oxygen-sensitive physiological challenges and interventions alter OS in subjects, allowing the 283 
oximetry capability of measurement systems to be assessed, and to provide useful calibration points 284 
for oximetry.[1,3,31,38,74] Further, these challenges and interventions provide physiological insights 285 
into metabolism.  286 
5.1.1. Hyperoxia 287 
Perhaps the most commonly used oxygen sensitive intervention is short duration hyperoxia (i.e. an 288 
excess of O2), where a subject breathes a high O2 (typically 100% O2) air mixture. Hyperoxia greatly 289 
increases the partial pressure of oxygen (pO2) in blood and increases both venous and arterial OS.  290 
Using the Oxymap system, Hardarson et al., (2006)[4]  reported that retinal arterial OS is increased 291 
from 96 ± 9% OS (mean  ±  SD) at normoxia to 101 ± 8 % OS at hyperoxia. Retinal veins experience a 292 
greater increase in OS from 55 ± 14 % to 78 ± 15%.[4] Using the Imedos system, Hammer et al., 293 
(2008)[9] reported that retinal arterial OS increased from 98 ± 10% (mean  ±  SD) at normoxia to 100 294 
± 10 % at hyperoxia and that retinal venous OS increased from 65 ± 12% at normoxia to 72 ± 10 % at 295 
hyperoxia.[9] Also using the Oxymap system, Klefter et al., (2014)[79] reported that retinal arterial OS 296 
increased from 95.1 ± 5.0% (mean  ±  SD) at normoxia to 96.6 ±  6.4% at hyperoxia and that retinal 297 
venous OS increased from 62.9 ± 6.7% at normoxia to 70.3 ± 7.8% at hyperoxia. Notably retinal and 298 
veins constricted in diameter by 5.5% and 8.2%, respectively at hyperoxia compared with normoxia. 299 
In all cases the increase in retinal venous OS was greater than the increase in retinal arterial OS. 300 
A hyperoxia intervention was used by Krisjandottir et al., (2013)[28] to show that all choroidal 301 
vessels are highly oxygenated at normoxia; this could only have been achieved with a hyperoxia 302 
intervention because two-wavelength oximetry calibration has not yet been demonstrated for 303 
choroidal vessels.[28] 304 
5.1.2. Hypoxia 305 
An alternative OS-sensitive intervention is acute mild hypoxia, where systematic OS is decreased 306 
by subjects inhaling a hypoxic air mixture (typically ~ 15% O2) for several minutes.  The 10 - 15 % OS 307 
decrease induced by acute mild hypoxia studies is similar in magnitude to the decrease in OS 308 
experience in high-altitude airplane travel [80] and thus can be considered safe in healthy subjects for 309 
short durations.  310 
Choudhary et al., (2013)[11] investigated the auto-regulatory effects of acute mild hypoxia in 311 
retinal vessels. OS was observed to decrease for both arterioles and venules but artery-vein (AV) OS 312 
difference remained constant. Both retinal arteries and veins were observed to dilate under hypoxia, 313 
with arteries showing a larger increase.[11] This provided new insight into the interplay between the 314 
vascular and choroidal oxygen supplies in the retina and auto-regulatory responses.  315 
MacKenzie et al., (2016)[32] utilised a similar hypoxia intervention to study bulbar conjunctival and 316 
episcleral oxygen dynamics. Episcleral vessels were observed to behave similarly to retinal vessels 317 
under acute mild hypoxia, but episcleral arteries and veins were not distinguished. However, hypoxic 318 
bulbar conjunctival vessels were observed to re-oxygenate to high OS via oxygen diffusion when 319 
exposed to ambient air. This effect would not have been possible to observe without the hypoxic 320 
intervention.[32] 321 
Severe graded hypoxia to as low as 9% O2 was used by Yi et al., (2015)[74] to investigate the 322 
metabolic response of the rat retina to hypoxia, finding that the metabolic demand of the retina is 323 
increased at hypoxia.[74] 324 
5.1.3. Retinal light exposure 325 
Retinal light exposure is known to alter retinal metabolic demand, thus inducing an autoregulation 326 
effect, and thus altering retinal OS. Using the Oxymap system, Hardarson et al., (2009)[8] found that 327 
retinal OS of both arteries and veins is higher in for an eye not exposed to light than for an eye exposed 328 
to light.[8] With the Imedos system, Hammer et al., (2011)[6] found that retinal venous OS increased 329 
by an average of ~ 5% after ~ 100s of  12.5 Hz flicker stimulation. In contrast, retinal arterial OS 330 
decreased slightly on average by ~ 1%. The diameter of both arteries and veins increased significantly, 331 
indicating increased blood flow. A later study by Hammer et al., (2012)[7] that compared diabetic 332 
patients to healthy controls found that venous OS of diabetic patients increased less under flicker 333 
stimulation than the change observed in healthy controls.[7] Similarly, venous dilation was less for 334 
diabetic patients than healthy controls. This suggests that retinal blood flow regulation is impaired in 335 
diabetic patients.[7] 336 
5.2. Eye-mimicking ex vivo oximetry phantoms 337 
Oximetry can be validated using ex vivo blood of various OS levels in in vitro phantoms that mimic 338 
blood vessels within the eye. Various strategies to phantom design and construction have been 339 
implemented. 340 
Lemaillet et al., (2009)[81] developed a multi-layered dynamic eye phantom, incorporating flowing 341 
blood to simulate in vivo blood flow. Flowing blood is known to have different reflectance and 342 
scattering parameters than static blood due to alignment of red blood cells in laminar flow 343 
conditions.[82,83] The phantom consisted of: a plano-convex lens to mimic the human lens, a choroid 344 
mimicking layer, and a layer mimicking the retinal pigment endothelium. A 100 µm capillary was 345 
supplied with flowing bovine blood from a reservoir, and OS was modified by adding sodium 346 
hydrosulphide to deoxygenate blood, with additional oxygen supplied via a fuel cell to the blood 347 
reservoir. It was noted that construction of this phantom was highly time consuming.[81] 348 
Mordant et al., (2011)[62] constructed a simple model eye consisting of straight quartz capillaries 349 
of various inner diameters (50, 100, and 150 µm) filled with static human blood (see Figure 4). A convex 350 
lens mimicked the human lens and distilled water mimicked the vitreous humour. A white diffuse 351 
reflectance material - Spectralon™ - mimicked the scleral back-reflectance.[30,84] Blood OS was varied 352 
by placing samples in air mixtures with varied fractions of O2 and OS was confirmed with a blood gas 353 
analyser.[62] This phantom was used to validate later in vivo oximetry studies.[51] 354 
MacKenzie et al., (2016)[32] constructed a simple sclera-mimicking phantom for bulbar 355 
conjunctival and episcleral oximetry. This phantom consisted of a 100 µm FEP plastic capillary above 356 
a Spectralon™ backing. The capillary was filled with flowing ex vivo equine blood and OS was varied by 357 
addition of sodium dithionite[66]; OS was confirmed with a blood gas analyser. Whilst not 358 
sophisticated, this phantom was sufficient for oximetry validation.[32] 359 
Recently, Ghassemi et al., (2015)[85,86] have reported a bio-mimicking phantom designed from 360 
real retinal blood vessel patterns. These phantoms are 3D printed from a photoreactive resin in a 361 
pattern based up a 3D sectioned image of retinal vessels. A commercially available O2Hb solution was 362 
used in place of whole blood. Yeast was used to consume oxygen in the solution, with OS decreasing 363 
over time.[85] Bio-mimicking phantoms may be advantageous in future because they could simulate 364 
realistic blood flow patterns and thus reproduce features like laminar flow seen in branching retinal 365 
veins.[42] 366 
Corcoran et al., (2014)[87] created an advanced, wide-field spherical eye with 3D-printed phantom 367 
retina, an optics based on a rigorous schematic eye model. The retina incorporated embedded image 368 
resolution test targets and simulated retinal tissue layers. This style of advanced phantom has not yet 369 
been applied to oximetry, but could be highly beneficial in future studies that more closely resemble 370 
in vivo applications.[87] 371 
 372 
Figure 4. Diagram of a model eye phantom used by Mordant et al., (2011)[62] to validate 373 
oximetry capability of a hyperspectral imaging system. Figure reproduced with 374 
permission. 375 
6. CLINICAL INSIGHTS  376 
 377 
6.1. Diabetic retinopathy 378 
 379 
Diabetic retinopathy is an important potentially blinding eye condition, which can affect patients 380 
in the working-age population. Diabetic retinopathy causes loss of capillaries in the retinal circulation, 381 
and visual loss can occur following the resultant retinal ischaemia, production of vaso-proliferative 382 
substances e.g. vascular endothelial growth factor (VEGF), and then misdirected growth of new 383 
vessels, which are fragile, and ultimately result in vitreous haemorrhage and/or retinal detachment. 384 
Diabetic visual loss can also follow leakage from retinal vessels close to the macula causing macular 385 
oedema. Research has explored the use of retinal oximetry to detect the effects on arterial and venous 386 
oxygen saturation of diabetic retinopathy. Early work by Beach et al. detailed acute changes in retinal 387 
oxygen utilisation with hyperglycaemia.[13] Later work, using dual-wavelength oximetry has 388 
demonstrated that higher venous oxygen saturation is associated with established diabetic 389 
retinopathy,[17] which, in some studies shows a dose-related relationship with increasing severity of 390 
proliferative diabetic retinopathy.[15,16] These observations might represent the formation of 391 
arterio-venous shunts in the retinal circulation to circumvent the capillary loss, or, alternatively, might 392 
simply represent reduced oxygen utilisation by pathologically atrophic inner retinal cellular elements. 393 
Elevated venous saturation in patients with diabetic retinopathy may be a clinically useful measure of 394 
underlying retinal ischaemia, and may become an indicator of the need for retinal photocoagulation 395 
treatment. Interestingly, application of retinal photocoagulation has not been shown to result in any 396 
significant changes in venous retinal OS.[15] 397 
 398 
6.2. Retinal vessel occlusion 399 
 400 
Retinal venous occlusion is an important cause of visual morbidity in older patients with general 401 
vascular risk factors, e.g. hypertension. The pathological effects of a central retinal vein occlusion may 402 
include retinal ischaemia, production of VEGF, and growth of new vessels, which can cause visual loss 403 
from vitreous haemorrhage, or neo-vascular glaucoma. Retinal oximetry research has been directed 404 
at detecting OS abnormalities. Such abnormalities might provide early evidence of retinal ischemia, 405 
and thus enable treatment to be applied at an earlier stage; hopefully reducing the risk of the patient 406 
developing neo-vascular glaucoma. Dual-wavelength oximetry research studies in central retinal 407 
venous occlusion have consistently shown lower levels of venous OS, consistent with generalised 408 
retinal ischaemia.[24, 25] Studies in partial, or branch, retinal occlusion have shown variable results, 409 
with sometimes increased, and sometimes reduced venous saturations. This may reflect the different, 410 
localised impact of a venous occlusion, and/or the maturity of the occlusion, as well as the impact of 411 
local homeostatic mechanisms.[23,26] Central retinal artery occlusion has been noted to result in 412 
severe retinal hypoxia, with low arteriovenous difference, suggesting cell death. 413 
 414 
6.3. Glaucoma 415 
 416 
Glaucoma is a common cause of blindness in older patients, and a family history of glaucoma is an 417 
important risk factor. The diagnosis of glaucoma rests on detection of characteristic changes at the 418 
optic nerve head which are associated with visual field loss. Many, but not all, patients with glaucoma 419 
will have elevated intraocular pressure. The pathological change, which ultimately results in visual loss 420 
is retinal ganglion cell axon loss, which essentially results in atrophy of the cellular elements of the 421 
inner retina. Oximetry studies have investigated the changes in oxygen consumption within the retinal 422 
circulation that are associated with the cellular loss. Research work using both dual wavelength and 423 
multispectral imaging has demonstrated elevated venous saturation, with some studies showing 424 
increasingly elevated venous saturation in more severely affected eyes.[18–22] These studies suggest 425 
a role for retinal oximetry as a means to estimate inner retinal oxygen consumption in glaucoma and 426 
other optic neuropathies. Further research is required to investigate whether interventions to lower 427 
the intraocular pressure might demonstrate reversible changes in oxygen utilisation, which could be 428 
a favourable prognostic outcome from the intervention. 429 
 430 
7. EXPERT COMMENTARY 431 
Oximetry in the eye has revealed a great deal about physiological norms and autoregulation in the 432 
retina. However, there is still considerable insight to be gleaned in application of oximetry to choroidal, 433 
episcleral, and bulbar conjunctival blood vessels. OS norms of these vessel beds require further study, 434 
and may provide insights into disease development and treatment.  435 
 436 
The advent of commercially available retinal oximetry systems, i.e. the Oxymap and Imedos 437 
systems have enabled retinal oximetry in the clinic, which has allowed studies of many retinal diseases 438 
with increasing statistical power. Clinical studies hold the potential to provide deeper insight into 439 
disease development and treatment of conditions such as diabetic retinopathy,[13–17] glaucoma,[18–440 
22] and retinal vessel occlusion.[23–26] 441 
 442 
The use of oxygen-sensitive interventions such as hyperoxia, hypoxia, and retinal light exposure 443 
have been able to compliment oximetry measurements on provide comparative intervention tests. In 444 
the retina a flicker intervention has enabled comparisons of the metabolic response of healthy control 445 
subjects and patients with diabetic retinopathy.[6] Notably, oxygen-sensitive interventions have 446 
enabled insight into the fundamental physiology of oxygen supply to the choroidal vessels,[28] 447 
episcleral circulation, and bulbar conjunctival circulation.[27] There is much potential in investigating 448 
these new targets for oximetry. 449 
 450 
The development of new technology and innovation in image processing is also helping to drive 451 
new oximetry applications that were not previously possible. With improved techniques, oximetry is 452 
now possible in small retinal vessels,[29] in the choroid,[28]  in the episcleral and bulbar conjunctival 453 
vessels,[32] and in the retina of infants.[68] New applications will invariably find new insights into the 454 
eye which are fundamentally and clinically important. 455 
 456 
One of the fundamental challenges for oximetry is validation of measurements. Arterial OS can be 457 
compared to invasive blood gas measurements or pulse oximetry. However, venous calibration is 458 
extremely challenging, and is influenced by blood vessel diameter and fundus pigmentation.[9,31] 459 
Multispectral algorithms offer a ‘calibration free’ oximetry method, but accurate validation is still 460 
highly challenging due to the complex optical environment of the eye. Validation with ex vivo blood is 461 
also complicated by numerous factors including blood aggregation, red blood cell death, alignment of 462 
red blood cells under flow, and imperfect phantoms.[12,51,81] 463 
 464 
Five-year view 465 
In the last five years, oximetry has revealed the fundamental physiology of OS in episcleral 466 
vessels,[27] the bulbar conjunctival vessels,[27] and the choroidal circulation.[28] The physiology 467 
understanding of these vessel beds has been enabled by the development of hyperoxia and hypoxia 468 
OS-sensitive interventions.  469 
Application of oximetry to the eye is continuing to yield fresh insight into the physiology of the eye 470 
and ocular disease development, and treatment. Commercially available two-wavelength oximetry 471 
systems have enabled oximetry in the clinic and studies of diseases such as diabetic retinopathy, vessel 472 
occlusion, and glaucoma have resulted. In the next five years, oximetry will likely be applied to 473 
increasingly diverse disease applications. 474 
Imaging technology and imaging analysis is also continuing to develop, pushing new boundaries in 475 
spatial and temporal resolution. This can enable oximetry in new applications, such as the study of 476 
small retinal vessels,[29] oximetry in infants,[68] in ex vivo red blood cells.[46] The advent of 3D 477 
printing has allowed the development of bio-mimicking phantoms[87] based on real blood vessel 478 
network patterns,[85] enabling the study of blood flow in realistic yet controlled scenarios. The fast 479 
paced development of 3D printing makes this field of phantom development particularly promising.  480 
Key issues  481 
 Spectroscopic oximetry is most widely applied to the study of the retinal circulation, but 482 
oximetry of the bulbar conjunctival, episcleral, and choroidal circulations has also recently 483 
emerged. 484 
 Oxygen-sensitive interventions such as hyperoxia, hypoxia, and retinal flicker illumination 485 
provide oximetry validation, clinical insights, and have revealed fundamental physiology of 486 
the choroid, the episcleral vessels, and the bulbar conjunctival vessels. 487 
 Commercial oximetry systems have enabled clinical studies in individual patients and in larger 488 
group studies, enabling deeper understanding of the development and treatment of diseases 489 
such as diabetes, retinal vessel occlusion, and glaucoma.  490 
 Development of new imaging capabilities, advanced image processing concepts, and ever-491 
improving phantom development are continuing to push new oximetry applications and 492 
enable fresh insights into the physiology of the eye. 493 
 494 
7. CONCLUSIONS 495 
Oximetry has enabled many insights in the fundamental physiology and oxygen dynamics of the 496 
eye. In particular, oximetry has enabled the study of retinal autoregulation, retinal disease 497 
development, and retinal disease treatment. Recently, the fundamental oxygen dynamics of the 498 
bulbar conjunctiva, the episcleral vessels, and the choroid have been revealed by oximetry combined 499 
with complimentary OS-sensitive hyperoxia and hypoxia interventions. 500 
Commercially available retinal oximetry systems have enabled oximetry in the clinic, allowing 501 
studies of retinal OS in many diseases and treatments. In particular, diabetic retinopathy, retinal 502 
vascular occlusion, and glaucoma. Oxygen sensitive interventions - such as retinal flicker illumination, 503 
hypoxia, and hyperoxia - have provided means to validate oximetry, establish physiological norms, 504 
and probe auto-regulation responses.  505 
The predominant imaging systems in the field of retinal oximetry are based upon modified retinal-506 
fundus cameras, however SLO-based systems show considerable promise with a comparatively larger 507 
field of view, the potential for improved spatial and depth resolution and accuracy. Further, SLOs 508 
require no mydriasis. Yet, existing SLO systems are limited to commercially favoured laser 509 
wavelengths, and as such may provide sub-optimal oximetry measurements. Confocal SLOs offer 510 
potential for improved accuracy through improved control of stray light and the longer effect path 511 
lengths enable good oximetric contrast with a wide range of low-cost infrared lasers, although optical 512 
efficiency is necessarily lower. Further development of SLO oximetry systems is a particularly fertile 513 
area. 514 
New oximetry applications are currently emerging, namely oximetry of the small retinal vessels, 515 
retinal oximetry in infants, and oximetry of the bulbar conjunctiva, episcleral, and choroidal vessels. 516 
These new applications for oximetry will enable researchers to understand the OS in physiological 517 
norms and disease across multiple ocular blood vessel beds. 518 
  519 
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